Annual EBIT
$198.52 M
+$80.63 M+68.40%
31 December 2023
Summary:
Amphastar Pharmaceuticals annual earnings before interest & taxes is currently $198.52 million, with the most recent change of +$80.63 million (+68.40%) on 31 December 2023. During the last 3 years, it has risen by +$193.51 million (+3861.62%). AMPH annual EBIT is now at all-time high.AMPH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$54.38 M
-$4.47 M-7.60%
30 September 2024
Summary:
Amphastar Pharmaceuticals quarterly earnings before interest & taxes is currently $54.38 million, with the most recent change of -$4.47 million (-7.60%) on 30 September 2024. Over the past year, it has dropped by -$22.96 million (-29.68%). AMPH quarterly EBIT is now -29.68% below its all-time high of $77.34 million, reached on 30 September 2023.AMPH Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$220.52 M
-$22.96 M-9.43%
30 September 2024
Summary:
Amphastar Pharmaceuticals TTM earnings before interest & taxes is currently $220.52 million, with the most recent change of -$22.96 million (-9.43%) on 30 September 2024. Over the past year, it has increased by +$31.02 million (+16.37%). AMPH TTM EBIT is now -9.43% below its all-time high of $243.48 million, reached on 30 June 2024.AMPH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMPH EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +68.4% | -29.7% | +16.4% |
| 3 y3 years | +3861.6% | +42.5% | +332.1% |
| 5 y5 years | +2150.2% | +3290.3% | +269.3% |
AMPH EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3861.6% | -29.7% | +134.8% | -9.4% | +332.1% |
| 5 y | 5 years | at high | +2150.2% | -29.7% | +917.3% | -9.4% | +4971.8% |
| alltime | all time | at high | +734.2% | -29.7% | +642.8% | -9.4% | +842.0% |
Amphastar Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $54.38 M(-7.6%) | $220.52 M(-9.4%) |
| June 2024 | - | $58.85 M(+4.2%) | $243.48 M(+10.2%) |
| Mar 2024 | - | $56.49 M(+11.2%) | $221.04 M(+11.3%) |
| Dec 2023 | $198.52 M(+68.4%) | $50.80 M(-34.3%) | $198.52 M(+4.8%) |
| Sept 2023 | - | $77.34 M(+112.4%) | $189.50 M(+40.0%) |
| June 2023 | - | $36.41 M(+7.2%) | $135.33 M(+10.5%) |
| Mar 2023 | - | $33.97 M(-18.7%) | $122.47 M(+3.9%) |
| Dec 2022 | $117.89 M(+38.7%) | $41.79 M(+80.4%) | $117.89 M(+14.0%) |
| Sept 2022 | - | $23.16 M(-1.6%) | $103.43 M(-12.7%) |
| June 2022 | - | $23.55 M(-19.9%) | $118.44 M(+8.5%) |
| Mar 2022 | - | $29.39 M(+7.5%) | $109.19 M(+28.4%) |
| Dec 2021 | $85.02 M(+1596.7%) | $27.33 M(-28.4%) | $85.02 M(+66.6%) |
| Sept 2021 | - | $38.17 M(+166.9%) | $51.04 M(+153.7%) |
| June 2021 | - | $14.30 M(+174.1%) | $20.12 M(+362.7%) |
| Mar 2021 | - | $5.22 M(-178.4%) | $4.35 M(-13.2%) |
| Dec 2020 | $5.01 M(-91.7%) | -$6.65 M(-191.7%) | $5.01 M(-61.1%) |
| Sept 2020 | - | $7.25 M(-593.7%) | $12.89 M(+78.0%) |
| June 2020 | - | -$1.47 M(-125.0%) | $7.25 M(-89.6%) |
| Mar 2020 | - | $5.88 M(+378.5%) | $69.83 M(+15.7%) |
| Dec 2019 | $60.35 M(-723.2%) | $1.23 M(-23.4%) | $60.35 M(+1.1%) |
| Sept 2019 | - | $1.60 M(-97.4%) | $59.71 M(-1.8%) |
| June 2019 | - | $61.12 M(-1796.3%) | $60.80 M(-1477.2%) |
| Mar 2019 | - | -$3.60 M(-710.7%) | -$4.42 M(-54.4%) |
| Dec 2018 | -$9.68 M | $590.00 K(-78.1%) | -$9.68 M(-14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $2.70 M(-165.8%) | -$11.28 M(-28.7%) |
| June 2018 | - | -$4.10 M(-53.8%) | -$15.83 M(+90.2%) |
| Mar 2018 | - | -$8.87 M(+777.4%) | -$8.32 M(-470.9%) |
| Dec 2017 | $2.08 M(-86.7%) | -$1.01 M(-45.4%) | $2.24 M(-237.7%) |
| Sept 2017 | - | -$1.85 M(-154.3%) | -$1.63 M(-125.1%) |
| June 2017 | - | $3.41 M(+101.2%) | $6.50 M(-50.6%) |
| Mar 2017 | - | $1.70 M(-134.7%) | $13.15 M(-16.0%) |
| Dec 2016 | $15.65 M(-266.9%) | -$4.88 M(-177.8%) | $15.65 M(-49.6%) |
| Sept 2016 | - | $6.28 M(-37.5%) | $31.08 M(+49.8%) |
| June 2016 | - | $10.06 M(+139.5%) | $20.75 M(+2956.7%) |
| Mar 2016 | - | $4.20 M(-60.2%) | $679.00 K(-107.2%) |
| Dec 2015 | -$9.38 M(-46.5%) | $10.54 M(-360.7%) | -$9.38 M(-64.3%) |
| Sept 2015 | - | -$4.04 M(-59.6%) | -$26.29 M(-11.6%) |
| June 2015 | - | -$10.02 M(+71.1%) | -$29.72 M(+40.8%) |
| Mar 2015 | - | -$5.86 M(-8.0%) | -$21.10 M(+20.3%) |
| Dec 2014 | -$17.54 M(-196.4%) | -$6.37 M(-14.9%) | -$17.54 M(+114.7%) |
| Sept 2014 | - | -$7.48 M(+434.3%) | -$8.17 M(+5069.6%) |
| June 2014 | - | -$1.40 M(-38.9%) | -$158.00 K(-101.2%) |
| Mar 2014 | - | -$2.29 M(-176.3%) | $13.40 M(-26.3%) |
| Dec 2013 | $18.18 M(-31.8%) | $3.00 M(+466.6%) | $18.18 M(+19.8%) |
| Sept 2013 | - | $530.00 K(-95.6%) | $15.18 M(+3.6%) |
| June 2013 | - | $12.16 M(+387.0%) | $14.65 M(+487.0%) |
| Mar 2013 | - | $2.50 M | $2.50 M |
| Dec 2012 | $26.66 M(-185.2%) | - | - |
| Dec 2011 | -$31.30 M | - | - |
FAQ
- What is Amphastar Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual EBIT year-on-year change?
- What is Amphastar Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly EBIT year-on-year change?
- What is Amphastar Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals TTM EBIT year-on-year change?
What is Amphastar Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of AMPH is $198.52 M
What is the all time high annual EBIT for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual earnings before interest & taxes is $240.29 M
What is Amphastar Pharmaceuticals annual EBIT year-on-year change?
Over the past year, AMPH annual earnings before interest & taxes has changed by +$80.63 M (+68.40%)
What is Amphastar Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of AMPH is $54.38 M
What is the all time high quarterly EBIT for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly earnings before interest & taxes is $77.34 M
What is Amphastar Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, AMPH quarterly earnings before interest & taxes has changed by -$22.96 M (-29.68%)
What is Amphastar Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of AMPH is $220.52 M
What is the all time high TTM EBIT for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high TTM earnings before interest & taxes is $243.48 M
What is Amphastar Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, AMPH TTM earnings before interest & taxes has changed by +$31.02 M (+16.37%)